Top

Published in:

01-05-2020 | Fosfomycin | Clinical study

Effect of FDA boxed warning on fluoroquinolone stewardship

Published in: Reactions Weekly | Issue 1/2020

Excerpt

A retrospective review of antibiotic prescribing before and after an updated US FDA boxed warning on inappropriate fluoroquinolone use did not find a significant difference, according to study results reported in Pharmacoepidemiology and Drug Safety, supporting "the need for efforts to counter inappropriate fluoroquinolone prescriptions for common illnesses". …

Bratsman A, et al. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning. Pharmacoepidemiology and Drug Safety : 11 May 2020. Available from: URL: http://doi.org/10.1002/pds.5018

Title: Effect of FDA boxed warning on fluoroquinolone stewardship
Publication date: 01-05-2020
Publisher: Springer International Publishing
Keywords: Fosfomycin
Nitrofurantoin
Antibiotic
Bronchitis
Published in: Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-78718-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effect of FDA boxed warning on fluoroquinolone stewardship

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

US guidance issued for postmarketing AE reporting during pandemic

Mycophenolate mofetil

Infliximab

Docetaxel

Nivolumab

Carboplatin